Maks_Lab/iStock via Getty Images
- UCB (OTCPK:UCBJF) has completed its acquisition of Zogenix (ZGNX), a deal valued at up to $1.9B.
- The Belgian company acquired Zogenix (ZGNX) for $26 per share plus a milestone-based contingent value right for a potential cash payment of $2 per share.
- As a result, Zogenix (ZGNX) was delisted from NASDAQ earlier todaty.
- Check out UCB's (OTCPK:UCBJY +1.1%) most recent earnings from February.